Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer

O. Caffo, G. Facchini, E. Biasco, F. Ferraù, F. Morelli, M. Donini, C. Buttigliero, N. Calvani, A. Guida, V.E. Chiuri, U. Basso, C. Mucciarini, V. Conteduca, S. Rossetti, A. Veccia, F. Maines, S. Kinspergher, U.D. Giorgi

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1115-1123
Number of pages9
JournalFuture Oncology
Volume15
Issue number10
DOIs
Publication statusPublished - 2019

Cite this

Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer. / Caffo, O.; Facchini, G.; Biasco, E.; Ferraù, F.; Morelli, F.; Donini, M.; Buttigliero, C.; Calvani, N.; Guida, A.; Chiuri, V.E.; Basso, U.; Mucciarini, C.; Conteduca, V.; Rossetti, S.; Veccia, A.; Maines, F.; Kinspergher, S.; Giorgi, U.D.

In: Future Oncology, Vol. 15, No. 10, 2019, p. 1115-1123.

Research output: Contribution to journalArticle

Caffo, O, Facchini, G, Biasco, E, Ferraù, F, Morelli, F, Donini, M, Buttigliero, C, Calvani, N, Guida, A, Chiuri, VE, Basso, U, Mucciarini, C, Conteduca, V, Rossetti, S, Veccia, A, Maines, F, Kinspergher, S & Giorgi, UD 2019, 'Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer', Future Oncology, vol. 15, no. 10, pp. 1115-1123. https://doi.org/10.2217/fon-2018-0715
Caffo, O. ; Facchini, G. ; Biasco, E. ; Ferraù, F. ; Morelli, F. ; Donini, M. ; Buttigliero, C. ; Calvani, N. ; Guida, A. ; Chiuri, V.E. ; Basso, U. ; Mucciarini, C. ; Conteduca, V. ; Rossetti, S. ; Veccia, A. ; Maines, F. ; Kinspergher, S. ; Giorgi, U.D. / Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer. In: Future Oncology. 2019 ; Vol. 15, No. 10. pp. 1115-1123.
@article{e5e965e684c5480da8d790012a6818c7,
title = "Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer",
author = "O. Caffo and G. Facchini and E. Biasco and F. Ferra{\`u} and F. Morelli and M. Donini and C. Buttigliero and N. Calvani and A. Guida and V.E. Chiuri and U. Basso and C. Mucciarini and V. Conteduca and S. Rossetti and A. Veccia and F. Maines and S. Kinspergher and U.D. Giorgi",
note = "Export Date: 26 June 2019",
year = "2019",
doi = "10.2217/fon-2018-0715",
language = "English",
volume = "15",
pages = "1115--1123",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "10",

}

TY - JOUR

T1 - Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer

AU - Caffo, O.

AU - Facchini, G.

AU - Biasco, E.

AU - Ferraù, F.

AU - Morelli, F.

AU - Donini, M.

AU - Buttigliero, C.

AU - Calvani, N.

AU - Guida, A.

AU - Chiuri, V.E.

AU - Basso, U.

AU - Mucciarini, C.

AU - Conteduca, V.

AU - Rossetti, S.

AU - Veccia, A.

AU - Maines, F.

AU - Kinspergher, S.

AU - Giorgi, U.D.

N1 - Export Date: 26 June 2019

PY - 2019

Y1 - 2019

U2 - 10.2217/fon-2018-0715

DO - 10.2217/fon-2018-0715

M3 - Article

VL - 15

SP - 1115

EP - 1123

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 10

ER -